NASDAQ:MEIP
Delisted

Mei Pharma Stock News

etoro logo Buy MEIP
*Your capital is at risk
$3.07
+0 (+0%)
At Close: Dec 09, 2025
Squarepoint Ops LLC purchased a new position in shares of MEI Pharma, Inc. (NASDAQ:MEIP) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 101,993 shares of the companys stock, valued at approximately $291,000. Squarepoint Ops LLC owned 0.09% of MEI Pharma at the end of []
Brokerages expect that MEI Pharma, Inc. (NASDAQ:MEIP) will announce earnings of ($0.19) per share for the current quarter, Zacks reports. Three analysts have made estimates for MEI Pharmas earnings, with the highest EPS estimate coming in at ($0.11) and the lowest estimate coming in at ($0.24). MEI Pharma reported earnings of ($0.22) per share in []
Related Stocks: EPZM , MRUS , ADCT , YMAB , MEIP , NTLA , BCRX , CYTK , VSTM , GERN ,
10 penny stocks to watch this week. The post 10 Top Penny Stocks To Watch With Potential Biotech Catalysts This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 0.00% and 34.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
MEI Pharma, Inc. (MEIP) CEO Dan Gold on Q4 2021 Results - Earnings Call Transcript
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 100.00% and 95.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
SAN DIEGO , Sept. 2, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will present a com
Mei Pharma (MEIP) doses first patient in phase III study to evaluate zandelisib plus rituximab in follicular lymphoma or marginal zone lymphoma.
SAN DIEGO and TOKYO, Aug. 17, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa
SAN DIEGO, Aug. 5, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Brian Drazba, chief fi

MEI Pharma Appoints Tina C. Beamon, J.D.

08:00am, Wednesday, 07'th Jul 2021
SAN DIEGO, July 7, 2021 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the appointment of Tina C.
Penny stocks to watch with upcoming event dates to keep in mind this week The post Best Penny Stocks To Buy? 4 To Watch This Week With Potential Catalysts appeared first on Penny Stocks to Buy, Picks,
SAN DIEGO and TOKYO, June 9, 2021 /PRNewswire/ --  MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE